Cancer, Stem Cells + Cancer Stem Cells Flashcards

1
Q

What is a stem cell?

A

= undifferentiated cells that can self-renew

= divide asymmetrically or symmetrically in response to mitogens

= involved in maintenance and repair

= terminally differentiated cells lose ability to divide
= termed post-mitotic
=often short lived

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

What is the stem cell hierarchy?

A

Totipotent cells
= e.g. zygote
= capable of giving rise to all cell types of the body ad extra-embryonic tissues

Pluripotent
= e.g. blastocyst, embryonic stem cells, induced pluripotent cells
= capable of giving rise to all cell types of the body

Multipotent Stem cells / Adult stem cells
= e.g. ectodermal, mesodermal, endodermal progenitors
= capable of giving rise to all cells of a particular tissue organ

Lineage Commited
= e.g. neuronal cell, muscle cell, lung cell
= not usually capable of giving rise to other cell types

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

What do transit amplifying cells do?

A

= carry out the bulk of proliferation

committed transit amplifying cell = progenitor cells

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

What is the haematopoietic system?

A
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

What happens in Leukaemia?

A

The hierarchical control is lost

Leukaemia = often characterised by presence of poorly-differentiated blast-like cells in blood

Defined on cell of origin
= e.g. lymphoblastic, myeloblastic, erythroblastic

Loss of differentiation often tightly linked to hyperproliferative state

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Cell of origin in determining cancer / leukaemia type?

A

Haematopoietic system
= BCR-ABL oncogene causes
- CML if it arises in stem cell
- ALL if it arises in progenitor cell

PTC1 causes medulloblastoma whether it occurs in a neural stem cell or progenitor cell

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

What is the stem cell niche?

A

Stem cells respond to signals (mitogens) from local environment = stem cell niche

= provides a balance of growth stimulatory and inhibitory signals

= niche often located in region of tissue protected from external damage
(e.g. intestinal crypt, limbus, basal layer of skin)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

What is an example of a stem cell niche?

A

e.g. Wnt signalling in normal and APC null colon crypts

WT
= B-catenin: Tcf/Lef ON = target genes induced by Wnts
= proliferating, undifferentiated progenitors
= B-catenin: Tcf/Lef OFF = Cell cycle arrested, differentiated cells

APC KO
= cannot switch off B-catenin: Tcf/Lef = hyperproliferation
= APC or B-catenin mutation = progenitor-like phenotype site of future polyp formation
= can result in FAP

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

What is Familial Adenomatous Polyposis (FAP)?

A

Germline mutations in APC associated with FAP
= autosomal dominant
= 100% penetrant
= relatively rare

= patients show early development of 100-100s of polyps

(EXTRA READING)
= FAP linked to defects in stem cell niche
= mutations in genes involved in stem cell regulation (e.g. APC and Wnt) = linked to development of FAP

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

What is the cancer stem cell hypothesis?

A

(Normal) Clonal evolution model
= tumours are heterogenic (mix of cell types)

Cancer stem cell model
= not all cells recapitulate tumour heterogeneity

(EXTRA READING)
=tumours are hierarchically organised, contain small population of cells with stem cell-like properties responsible for tumour initiation, growth and recurrence = CSCs

= can self-renew, differentiate into various cell type within tumour = much like normal stem cells

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Cancer Stem Cells in AML?

A

Bonnet and Dick, presented in mid 1990s

Later presented first CSC detected in AML

= only subpopulation of human AML cells were able to proliferate in the NOD/ SCID mouse model (CD34+ / CD38-)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

What is Fluorescence-Activated Cell Sorting (FACS)?

A

(EXTRA READING)
=can isolate and sort cells based on physical and chemical properties using fluorescent dyes and laser technology

= cells labelled with fluorescent dyes or antibodies that target specific surface / cellular molecules

= cells sorted based on fluorescent properties

= can identify CSCs = then use in xenograft assays
= show long-term self-renewal capacity

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

What is Cancer Cell Plasticity?

A

Cells are able to navigate the hierarchy , can differentiate

(EXTRA READING)
= e.g. MET and EMT (metastasis)
can also undergo dedifferentiation = loss of specialised features - return to more stem cell -like state

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

What are the (4) key concepts in the cancer stem cell model? (Batlle and Clevers, 2017)

A
  1. Cellular heterogeneity observed in tumours results from its hierarchal organisation
  2. Hierarchies driven by rare, self-renewing CSCs, whereas bulk of tumour composed of non-CSCs
  3. CSC identity hardwired (seen by non-CSCs seldom initiating tumours in xenograft assays)
  4. CSCs are resistant to standard chemotherapy and radiation treatment, preferentially target non-CSCs - a phenomenon that explains relapse after treatment

(EXTRA READING)
= also PLASTICITY = CSCs undergo genetic and phenotypic changes in response to environmental cues
= also DIFFERENTIATION = CSCs differentiate into various cell types
= also TUMOUR-INITIATING ABILITY = CSCs initiate tumour growth (linked to recurrence)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Characteristics of CSCs?

A

CSCs = subpopulation of tumour cells , identified through expression of surface markers
(e.g. CD24, CD44, CD133, EpCAM = cell membrane glycoproteins)

Stem cells signals like MSI can be genetically + epigenetically modified in cancer
= MSI represses expression of NUMB which normally promotes differentiation
= oncogenic activation of MSI leads to aggressive undifferentiated state
= MSI2 activation seen in blast crisis in CML

(EXTRA READING)
= self-renewal
= differentiation
= tumour-initiating ability
= resistance to therapy
= increased tumorigenicity
= heterogeneity
= plasticity

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

What is the significance of CSCs?

A

Repsonsible for majority of cancer cells in a tumour
= BUT themselves do not comprise the tumour bulk

If CSCs not eliminated by cancer treatment
= will quickly repopulate the tumour

17
Q

How do CSCs resist treatment?

A

through “stemness”

CSCs have elevated drug efflux and DNA damage surveillance / repair

18
Q

What other selective advantages do CSCs promote?

A

Perivascular niche
= CSC promotes angiogenesis

Hypoxic niche
= CSCs can survive in low oxygen

19
Q

What are some controversies about CSCs?

A

How rare are CSCs / how important?

Does phenotypic plasticity occur? Can non-CSCs become CSCs and v.v?

How does it link to the clonal evolution model?

Does the NOD/ SCID mouse xenotransplant model have clinical relevance (in humans)?